EBV-gp350 Confers B-Cell Tropism to Tailored Exosomes and Is a Neo-Antigen in Normal and Malignant B Cells—A New Option for the Treatment of B-CLL

• Romana Ruiss,

  Affiliation Department of Gene Vectors, Helmholtz-Zentrum, Munich, Germany

  ⨯
• Simon Jochum,

  Affiliation Department of Gene Vectors, Helmholtz-Zentrum, Munich, Germany

  ⨯
• Ralph Mocikat,

  Affiliation Institut für Molekulare Immunologie, Helmholtz-Zentrum, Munich, Germany

  ⨯
• Wolfgang Hammerschmidt,

  Affiliation Department of Gene Vectors, Helmholtz-Zentrum, Munich, Germany

  ⨯
• Reinhard Zeidler

  * E-mail: Reinhard.Zeidler@med.lmu.de

  Affiliation Department of Otorhinolaryngology, Ludwig-Maximilians-Universität, Munich, Germany

  ⨯